EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 27 filers reported holding EVOKE PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $82,000 | +18.8% | 27,500 | 0.0% | 0.00% | – |
| Q2 2018 | $69,000 | +21.1% | 27,500 | 0.0% | 0.00% | – |
| Q1 2018 | $57,000 | +103.6% | 27,500 | +120.0% | 0.00% | – |
| Q4 2017 | $28,000 | -53.3% | 12,500 | -30.6% | 0.00% | – |
| Q3 2017 | $60,000 | +30.4% | 18,000 | 0.0% | 0.00% | – |
| Q2 2017 | $46,000 | -17.9% | 18,000 | 0.0% | 0.00% | – |
| Q1 2017 | $56,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 32,000 | $113,000 | 0.09% |
| Cetera Advisor Networks LLC | 30,260 | $107,000 | 0.00% |
| Creative Planning | 100,000 | $354,000 | 0.00% |
| OPTIMUM INVESTMENT ADVISORS | 800 | $3,000 | 0.00% |
| Lindbrook Capital, LLC | 1,000 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 37,438 | $133,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 188,514 | $667,000 | 0.00% |
| CITIGROUP INC | 500 | $2,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 35,174 | $125,000 | 0.00% |